CD8A and neoplasm: Furthermore, according to a recent study, TIGIT is expressed on tumor-infiltrating NK cells, and TIGIT blockade reverses the exhaustion of NK cells independently of the adaptive immune system, namely, CD8+ T cell-mediated tumor reactivity (24).